Skip to content
healthcare.dev

Dabigatran etexilate

NDC 43598-453, Dabigatran etexilate, capsule, from Dr.Reddys Laboratories Inc.

Product NDC
43598-453
Status
Listed
Labeler
Dr.Reddys Laboratories Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208048
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DABIGATRAN ETEXILATE MESYLATE110 mg/1

Pharmacologic classes

Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
43598-453-604359804536060 CAPSULE in 1 BOTTLE (43598-453-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a608e019-db9a-d6fb-cd0d-cecc1351a2b1
  • NADAC price for package 43598045360

    GET /v1/drugs/nadac/43598045360

Use it

Look up 43598-453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.